Home
FBLG
FBLG News

Latest FIBROBIOLOGICS INC (FBLG) News on April 2, 2025

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a day ago

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

FibroBiologics Announces 2025 Annual Meeting of Stockholders

GlobeNewswire

6 days ago

FibroBiologics Announces 2025 Annual Meeting of Stockholders

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

GlobeNewswire

12 days ago

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire

19 days ago

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Life Sciences Investor Forum Agenda Announced for March 13th

GlobeNewswire

21 days ago

Life Sciences Investor Forum Agenda Announced for March 13th

Uncovering Opportunities: 3 Penny Stocks With Market Caps Under $80M

Simply Wall St.

a month ago

Uncovering Opportunities: 3 Penny Stocks With Market Caps Under $80M

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

GlobeNewswire

a month ago

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

GlobeNewswire

a month ago

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

FBLG: Analyst Day Provides In-Depth Overview of Pipeline…

Zacks Small Cap Research

a month ago

FBLG: Analyst Day Provides In-Depth Overview of Pipeline…

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

GlobeNewswire

2 months ago

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

FibroBiologics And 2 Other US Penny Stocks To Watch

Simply Wall St.

2 months ago

FibroBiologics And 2 Other US Penny Stocks To Watch

MT Newswires

3 months ago

FibroBiologics Closes Second $5 Million Tranche of $25 Million Equity Purchase Agreement

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

GlobeNewswire

3 months ago

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

GlobeNewswire

3 months ago

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

MT Newswires

3 months ago

FibroBiologics Files Secondary Stock Shelf

MT Newswires

3 months ago

FibroBiologics Obtains up to $25 Million Financing

FibroBiologics Announces $25 Million Financing

GlobeNewswire

3 months ago

FibroBiologics Announces $25 Million Financing

Zacks Small Cap Research

4 months ago

FBLG: On Target to Initiate Phase 1/2 Trial in 2025…

MT Newswires

4 months ago

FibroBiologics Files Patent Application for Methods to Treat Splenomegaly

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

GlobeNewswire

4 months ago

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

GlobeNewswire

5 months ago

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

Is FibroBiologics (NASDAQ:FBLG) In A Good Position To Deliver On Growth Plans?

Simply Wall St.

5 months ago

Is FibroBiologics (NASDAQ:FBLG) In A Good Position To Deliver On Growth Plans?

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

5 months ago

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

GlobeNewswire

5 months ago

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

GlobeNewswire

5 months ago

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

FibroBiologics and Charles River link for chronic disease therapies manufacture

Pharmaceutical Technology

5 months ago

FibroBiologics and Charles River link for chronic disease therapies manufacture

MT Newswires

5 months ago

FibroBiologics, Charles River Laboratories Team Up to Make Fibroblast-Based Treatments for Chronic Diseases

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

GlobeNewswire

5 months ago

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

MT Newswires

6 months ago

FibroBiologics Gets European Patent for Cancer Treatment Using Modified Fibroblasts

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

GlobeNewswire

6 months ago

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

GlobeNewswire

6 months ago

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

GlobeNewswire

6 months ago

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

MT Newswires

6 months ago

FibroBiologics Enlists Southern Star for Contract Research Organization Services in Australia

FibroBiologics Engages Southern Star Research as CRO in Australia

GlobeNewswire

6 months ago

FibroBiologics Engages Southern Star Research as CRO in Australia

MT Newswires

7 months ago

FibroBiologics Files Patent Application for Fibroblast Cell-Based Technology

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

GlobeNewswire

7 months ago

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

7 months ago

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

MT Newswires

7 months ago

FibroBiologics Files US Patent Application for Wound Healing

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

GlobeNewswire

7 months ago

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

Zacks Small Cap Research

8 months ago

FBLG: Proof-of-Concept Data for Artificial Thymus Technology…

FibroBiologics Files 2024 Second Quarter Report

GlobeNewswire

8 months ago

FibroBiologics Files 2024 Second Quarter Report

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

GlobeNewswire

9 months ago

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

GlobeNewswire

9 months ago

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

Zacks Small Cap Research

9 months ago

FBLG: Cellular Therapies Using Fibroblasts; Initiating Coverage of FibroBiologics, Inc.

FibroBiologics Set to Join Russell 2000® Index

GlobeNewswire

10 months ago

FibroBiologics Set to Join Russell 2000® Index

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

10 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

10 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

10 months ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

10 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

10 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

10 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

10 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

10 months ago

Best Date Night Fragrance in 2024

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

10 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

10 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

10 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

10 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

10 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

10 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

10 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

10 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

GlobeNewswire

10 months ago

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

FibroBiologics Announces 2024 Annual Meeting of Stockholders

GlobeNewswire

a year ago

FibroBiologics Announces 2024 Annual Meeting of Stockholders

FibroBiologics Files 2024 First Quarter Report

GlobeNewswire

a year ago

FibroBiologics Files 2024 First Quarter Report

FibroBiologics to Present at the BIO International Convention 2024

GlobeNewswire

a year ago

FibroBiologics to Present at the BIO International Convention 2024

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

GlobeNewswire

a year ago

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

GlobeNewswire

a year ago

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

GlobeNewswire

a year ago

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

GlobeNewswire

a year ago

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

PR Newswire

a year ago

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

FibroBiologics to Present at Advanced Wound Care Summit USA

PR Newswire

a year ago

FibroBiologics to Present at Advanced Wound Care Summit USA

FibroBiologics Appoints Ruben A. Garcia as General Counsel

PR Newswire

a year ago

FibroBiologics Appoints Ruben A. Garcia as General Counsel

FibroBiologics Files 2023 Form 10-K Annual Report

PR Newswire

a year ago

FibroBiologics Files 2023 Form 10-K Annual Report

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum

PR Newswire

a year ago

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum

FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases

PR Newswire

a year ago

FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases

FibroBiologics Announces Three United States Patents for Fibroblast Technology

PR Newswire

a year ago

FibroBiologics Announces Three United States Patents for Fibroblast Technology

FibroBiologics Announces Three Japanese Patents on Fibroblast Technology

PR Newswire

a year ago

FibroBiologics Announces Three Japanese Patents on Fibroblast Technology

FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG

PR Newswire

a year ago

FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG

Share on Social Networks: